185 related articles for article (PubMed ID: 6349538)
1. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].
Taguchi T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):387-93. PubMed ID: 6349538
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey.
Taguchi T
Cancer Detect Prev Suppl; 1987; 1():333-49. PubMed ID: 3121179
[TBL] [Abstract][Full Text] [Related]
3. [Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Tohoku Lentinan Study Group].
Wakui A; Kasai M; Konno K; Abe R; Kanamaru R; Takahashi K; Nakai Y; Yoshida Y; Koie H; Masuda H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1050-9. PubMed ID: 3083785
[TBL] [Abstract][Full Text] [Related]
4. [Effect of lentinan administration of adrenalectomized rats and patients with breast cancer].
Kosaka A; Wani T; Hattori Y; Yamashita A
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1474-81. PubMed ID: 6764117
[TBL] [Abstract][Full Text] [Related]
5. [Results of phase III study of lentinan].
Taguchi T; Furue H; Kimura T; Kondo T; Hattori T; Itoh I; Ogawa N
Gan To Kagaku Ryoho; 1985 Feb; 12(2):366-78. PubMed ID: 3918510
[TBL] [Abstract][Full Text] [Related]
6. [TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report].
Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Matsuura N; Kikkawa N
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1791-3. PubMed ID: 14619521
[TBL] [Abstract][Full Text] [Related]
7. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group.
Nakano H; Namatame K; Nemoto H; Motohashi H; Nishiyama K; Kumada K
Hepatogastroenterology; 1999; 46(28):2662-8. PubMed ID: 10522061
[TBL] [Abstract][Full Text] [Related]
8. [Pilot study of TS-1 combined with lentinan in patients with unresectable or recurrent advanced gastric cancer].
Nimura H; Mitsumori N; Tsukagoshi S; Nakajima M; Atomi Y; Suzuki S; Kusano M; Yoshiyuki T; Tokunaga A
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1289-96. PubMed ID: 14518408
[TBL] [Abstract][Full Text] [Related]
9. [Provision for adverse effect of S-1 containing chemotherapy in patients with advanced digestive cancer--combination with superfine dispersed lentinan].
Yagi M; Watanabe S; Yoshino S; Hazama S; Suga T; Nakazawa S
Gan To Kagaku Ryoho; 2010 Mar; 37(3):457-62. PubMed ID: 20332683
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer.
Hazama S; Watanabe S; Ohashi M; Yagi M; Suzuki M; Matsuda K; Yamamoto T; Suga Y; Suga T; Nakazawa S; Oka M
Anticancer Res; 2009 Jul; 29(7):2611-7. PubMed ID: 19596936
[TBL] [Abstract][Full Text] [Related]
11. [Synergistic action of lentinan (LNT) with endocrine therapy of breast cancer in rats and humans].
Kosaka A; Kuzuoka M; Yamafuji K; Imaizumi A; Hattori Y; Yamashita A
Gan To Kagaku Ryoho; 1987 Feb; 14(2):516-22. PubMed ID: 3101609
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of TS-1 and lentinan combination immunochemotherapy in advanced or recurrent gastric cancer--pilot study aiming at a randomized trial].
Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Kikkawa N; Matsuura N
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1125-30. PubMed ID: 12938267
[TBL] [Abstract][Full Text] [Related]
13. [S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer].
Nimura H; Mitsumori N; Takahashi N; Kashimura H; Takayama S; Kashiwagi H; Yanaga K
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():106-9. PubMed ID: 16897983
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in immunopharmacology and therapeutic effects of polysaccharides.
Chihara G
Dev Biol Stand; 1992; 77():191-7. PubMed ID: 1426662
[TBL] [Abstract][Full Text] [Related]
15. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial.
Gordon M; Bihari B; Goosby E; Gorter R; Greco M; Guralnik M; Mimura T; Rudinicki V; Wong R; Kaneko Y
J Med; 1998; 29(5-6):305-30. PubMed ID: 10503166
[TBL] [Abstract][Full Text] [Related]
16. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
[TBL] [Abstract][Full Text] [Related]
17. Lentinan with S-1 and paclitaxel for gastric cancer chemotherapy improve patient quality of life.
Kataoka H; Shimura T; Mizoshita T; Kubota E; Mori Y; Mizushima T; Wada T; Ogasawara N; Tanida S; Sasaki M; Togawa S; Sano H; Hirata Y; Ikai M; Mochizuki H; Seno K; Itoh S; Kawai T; Joh T
Hepatogastroenterology; 2009; 56(90):547-50. PubMed ID: 19579640
[TBL] [Abstract][Full Text] [Related]
18. [TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer].
Nagahashi S; Suzuki H; Nishiwaki M; Okuda K; Kurosawa Y; Terada S; Sugihara T; Andou K; Hibi T
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1999-2003. PubMed ID: 15570928
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers.
Yoshino S; Tabata T; Hazama S; Iizuka N; Yamamoto K; Hirayama M; Tangoku A; Oka M
Anticancer Res; 2000; 20(6C):4707-11. PubMed ID: 11205205
[TBL] [Abstract][Full Text] [Related]
20. [A controlled study of AO-90, a methionine-free intravenous amino acid solution, in combination with 5-fluorouracil and mitomycin C in advanced gastric cancer patients (surgery group evaluation)].
Taguchi T; Kosaki G; Onodera T; Endo M; Nakagawara G; Sano K; Kaibara N; Kakegawa T; Nakano S; Kurihara M
Gan To Kagaku Ryoho; 1995 May; 22(6):753-64. PubMed ID: 7755383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]